Response to Checkpoint Inhibition and Targeted Therapy in Patients With Melanoma With Concurrent Haematological Malignancies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies
Eur. J. Cancer 2023 Jun 01;186(xx)27-37, OJ Van Not, AJM van den Eertwegh, JB Haanen, RS van Rijn, MJB Aarts, FWPJ van den Berkmortel, CU Blank, MJ Boers-Sonderen, MJM van Eijs, JB de Groot, GAP Hospers, E Kapiteijn, M de Meza, D Piersma, M Stevense-den Boer, AAM van der Veldt, G Vreugdenhil, MWJM Wouters, KPM Suijkerbuijk, WAM BlokxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.